Clinuvel Pharmaceuticals Limited (CLVLY) Q4 2025 Earnings Call Transcript


Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q4 2025 Earnings Conference Call August 28, 2025 4:00 AM ET

Company Participants

Malcolm Bull – Head of Australian Operations & Investor Relations
Peter Vaughan – Chief Financial Officer
Philippe Jacques Wolgen – MD & Director

Conference Call Participants

David Andrew Stanton – Jefferies LLC, Research Division
Mark Pachacz – Unidentified Company
Melissa Benson – Barrenjoey Markets Pty Limited, Research Division
Shane A. Storey – Wilsons Advisory and Stockbroking Limited, Research Division
Sinclair Currie – MA Moelis Australia Securities, Research Division
Thomas Wakim – Bell Potter Securities Limited, Research Division
Stella Mariss – Unidentified Company

Stella Mariss

Hello, everyone. Thank you for joining CLINUVEL’s investor webinar. I am Stella of Monsoon Communications. In today’s webinar, CLINUVEL will share their financial year 2025 results and operational highlights for year ended on 30th June 2025. [Operator Instructions] I will now hand over to Malcolm Bull, Head of Investor Relations and Australian operations to conduct the proceedings.

Malcolm Bull

Thank you for the introduction, Stella, and also thanks to Monsoon Communications, who are facilitating yet another investor webinar for us. It’s pleasing we have more than 190 participants on the line from around the world, and we thank you for your interest in CLINUVEL. I will say that some shareholders have told us they prefer a shorter 30-minute type webinar, but we have extended today’s webinar at the request of several institutions to 45 minutes. And that reflects the number of questions that we’ve received as well.

So our webinar will be in 3 parts. The first part is to discuss the financial and operating results of the 2025 financial year, as Stella mentioned, with Managing Director, Dr. Philippe Wolgen, and Chief Financial Officer, Peter Vaughan. Welcome, gentlemen.

Peter Vaughan

Good morning and good evening.

Philippe Jacques Wolgen

Good



#Clinuvel #Pharmaceuticals #Limited #CLVLY #Earnings #Call #Transcript

Leave a Reply

Your email address will not be published. Required fields are marked *